Divi’s Laboratories Limited shares fell 2.75% in Indian trading Wednesday after a previous-session gain; a Nov. 7 filing separately showed higher quarterly revenue and profit.
Broker Choice quoted the shares at ₹11,248 at 1:20 a.m. ET (06:20 UTC), below the previous close of ₹11,565.50. The stock had reached ₹11,800.50 earlier in the session. The Economic Times later reported a price of ₹11,211.50 at 2:15:27 a.m. ET (07:15:27 UTC).
Divi’s Nov. 7 filing with the National Stock Exchange of India showed consolidated revenue from operations of ₹3,676 crore for the quarter ended Sept. 30, up from ₹2,715 crore a year earlier. Profit rose to ₹1,127 crore from ₹689 crore. Divi’s manufactures active pharmaceutical ingredients, intermediates and nutraceutical ingredients.
Choice recorded a 4.22% gain on Nov. 9, when the shares closed at ₹11,565.50.
